Enhancing Cystic Fibrosis Immune Regulation
In cystic fibrosis (CF), sustained infection and exuberant inflammation results in debilitating and often fatal lung disease. Advancement in CF therapeutics has provided successful treatment regimens for a variety of clinical consequences in CF; however effective means to treat the pulmonary infecti...
Main Authors: | Anna M. van Heeckeren, Morgan T. Sutton, David R. Fletcher, Craig A. Hodges, Arnold I. Caplan, Tracey L. Bonfield |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-05-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2021.573065/full |
Similar Items
-
Stem Cells: Innovations in Clinical Applications
by: Morgan T. Sutton, et al.
Published: (2014-01-01) -
Donor‐defined mesenchymal stem cell antimicrobial potency against nontuberculous mycobacterium
by: Tracey L. Bonfield, et al.
Published: (2021-08-01) -
Mesenchymal Stem Cells in Tissue Repair
by: Amy M DiMarino, et al.
Published: (2013-09-01) -
Chronic asthma and Mesenchymal stem cells: Hyaluronan and airway remodeling
by: Benjamin D. Goldstein, et al.
Published: (2017-08-01) -
Antimicrobial Properties of Mesenchymal Stem Cells: Therapeutic Potential for Cystic Fibrosis Infection, and Treatment
by: Morgan T. Sutton, et al.
Published: (2016-01-01)